Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab

Código QR

Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab

Milena L Cavalcante,1 Victor M Villegas,2 Aaron S Gold,2 Ludimila L Cavalcante,1 Marcela Lonngi,1 Nisha V Shah,1 Timothy G Murray2 1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA; 2Murray Ocular Oncology and Retina, Miami, FL, USA Objective: To report t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cavalcante ML, Villegas VM, Gold AS, Cavalcante LL, Lonngi M, Shah NV, Murray TG
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/b44d055d844946688f90302fa72ff7fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
por: Villegas VM, et al.
Publicado: (2014)

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
por: Houston SK, et al.
Publicado: (2013)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala NV, et al.
Publicado: (2014)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Neeraj Pandey, et al.
Publicado: (2010)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Kubota-Taniai M, et al.
Publicado: (2011)

Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah NV, et al.
Publicado: (2012)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Jia-Kang Wang, et al.
Publicado: (2018)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Mamdouh M Kabeel, et al.
Publicado: (2008)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
por: Yoshikawa T, et al.
Publicado: (2015)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ioannis D Ladas, et al.
Publicado: (2008)

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
por: Kitahashi M, et al.
Publicado: (2014)

Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
por: Shah NV, et al.
Publicado: (2013)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Juan Carlos Mesa Guti&eacute;rrez, et al.
Publicado: (2008)

Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
por: Mario R Romano, et al.
Publicado: (2010)

Optical coherence tomography angiography in choroidal melanoma and nevus
por: Ghassemi F, et al.
Publicado: (2018)

Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease
por: Feucht N, et al.
Publicado: (2013)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat A, et al.
Publicado: (2021)

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin&reg;) for AMD followed by controlateral sympathetic ophthalmia
por: Dimitrios Brouzas, et al.
Publicado: (2009)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa R, et al.
Publicado: (2012)

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
por: Gokce G, et al.
Publicado: (2014)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
por: Eltutar K, et al.
Publicado: (2013)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban AA, et al.
Publicado: (2012)

Case of endophthalmitis following intravitreal injections of bevacizumab
por: Shinya Komori, et al.
Publicado: (2010)

Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in na&iuml;ve myopic choroidal neovascularization
por: Bergamini F, et al.
Publicado: (2012)

Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study
por: Korol AR, et al.
Publicado: (2016)

Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
por: Hirose M, et al.
Publicado: (2014)

Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients
por: Isola V, et al.
Publicado: (2013)

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy
por: Ashraf M El-Batarny
Publicado: (2009)

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
por: Lemos-Reis R, et al.
Publicado: (2014)

Pharmacokinetics of intravitreal bevacizumab (Avastin&reg;) in rabbits
por: Sinapis C, et al.
Publicado: (2011)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011)

Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis
por: Ludimila L Cavalcante, et al.
Publicado: (2010)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi M, et al.
Publicado: (2013)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai MJ, et al.
Publicado: (2018)

Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
por: Kartasasmita A, et al.
Publicado: (2019)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho G, et al.
Publicado: (2020)

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
por: Jeon S, et al.
Publicado: (2014)

Acute sterile endophthalmitis following intravitreal bevacizumab: case series
por: Orozco-Hernández A, et al.
Publicado: (2014)

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
por: Antonopoulos C, et al.
Publicado: (2011)

Disaster Preparedness Impact In A Complex Ophthalmology Practice: A Review Of Patients Receiving Intravitreal Injections
por: El Hamichi S, et al.
Publicado: (2019)